856562-58-8

Upstream product

• 61072-56-8 4-chloro-2-fluorobenzaldehyde 
• 343338-28-3 (S)-2-methylpropane-2-sulfinamide 

Downstream Products

• 856562-68-0 (S)-N-((R)-1-(4-chloro-2-fluorophenyl)ethyl)-2-methylpropane-2-sulfinamide 
• 1433401-94-5 (S)-2-methyl-propane-2-sulfinic acid [(R)-(4-chloro-2-fluoro-phenyl)-cyclopropyl-methyl]-amide 
• 1433402-02-8 (S)-2-methylpropane-2-sulfinic acid [(S)-(4-chloro-2-fluorophenyl)cyclopropylmethyl]amide 
• 1433402-10-8 [(R)-(4-chloro-2-fluoro-phenyl)-cyclopropyl-methyl]-carbamic acid tert-butyl ester 
• 1213360-40-7 C₁₀H₁₁ClFN 
• 1433404-96-6 tert-butyl N-[(R)-{3-[(4-{[(tert-butyldimethylsilyl)oxy]methyl}phenyl)carbonyl]-4-chloro-2-fluorophenyl}(cyclopropyl)methyl]carbamate 
• 1433403-85-0 tert-butyl N-[(R)-{3-[(6-aminopyridin-3-yl)carbonyl]-4-chloro-2-fluorophenyl}(cyclopropyl)methyl]carbamate 
• 1433403-77-0 tert-butyl N-[(R)-{3-[(6-bromopyridin-3-yl)carbonyl]-4-chloro-2-fluorophenyl}(cyclopropyl)methyl]carbamate 

Relevant academic research and scientific papers

PHARMACEUTICAL COMPOUNDS

The invention provides compounds that are useful in the treatment of hepatitis C virus (HCV) infections. The compounds have the formula (1): or a salt, N-oxide, tautomer or stereoisomer thereof, wherein A is CH or N; E is CH or N; R1 is selecte

SUBSTITUTED BENZYLAMINE COMPOUNDS, THEIR USE IN MEDICINE, AND IN PARTICULAR THE TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTION

The invention provides compounds of the formula (I): or a salt, N-oxide or tautomer thereof, wherein A is CH, CF or nitrogen; E is CH, CF or nitrogen; and R0 is hydrogen or C1-2 alkyl; R1a is selected from CONH2

AROMATIC COMPOUND

An aromatic compound represented by the following formula or a pharmaceutically acceptable salt thereof: , wherein ring A is a heterocyclic ring, ring B is a carbocyclic ring, a heterocyclic ring etc., G1, G2, G3, G4 and G5 are CH or N, X is -NH-, -O-, -CH2-, etc., Y is - CH2-,-CO-,-SO2- etc., Z is a single bond, -CO-, -SO2-, -NH-, -O-, -S-, -CONH-,-SO2NH-, etc., R2 is hydrogen, alkyl, alkoxy, halogen, etc., and R3 is carbocyclic group, heterocyclic group, alkyl, etc., is useful as a controlling agent of the function of CCR4 useful for the treatment or therapy for bronchial asthma, atopic dermatitis, etc.